Neuberger Berman Group LLC Ultragenyx Pharmaceutical Inc. Transaction History

Neuberger Berman Group LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$43.02 - $53.69 $4.51 Million - $5.63 Million	104,939 New	104,939 $4.9 Million
Q4 2023 Feb 09, 2024	SELL	$31.73 - $49.19 $2.01 Million - $3.11 Million	-63,240 Reduced 47.55%	69,746 $3.34 Million
Q3 2023 Nov 14, 2023	BUY	$34.92 - $46.66 $1.06 Million - $1.42 Million	30,341 Added 29.56%	132,986 $4.74 Million
Q2 2023 Aug 11, 2023	BUY	$37.35 - $52.15 $1.27 Million - $1.77 Million	33,969 Added 49.46%	102,645 $4.74 Million
Q1 2023 May 12, 2023	BUY	$36.99 - $48.71 $1.07 Million - $1.41 Million	28,890 Added 72.61%	68,676 $2.75 Million
Q4 2022 Feb 13, 2023	BUY	$33.72 - $46.33 $1.34 Million - $1.84 Million	39,786 New	39,786 $1.84 Million
Q2 2021 Aug 13, 2021	SELL	$92.19 - $115.71 $1.71 Million - $2.15 Million	-18,585 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$106.9 - $167.73 $645,889 - $1.01 Million	-6,042 Reduced 24.53%	18,585 $2.12 Million
Q4 2020 Feb 10, 2021	SELL	$84.4 - $177.39 $200,281 - $420,946	-2,373 Reduced 8.79%	24,627 $3.41 Million
Q3 2020 Nov 12, 2020	BUY	$72.98 - $90.0 $510,860 - $630,000	7,000 Added 35.0%	27,000 $2.22 Million
Q2 2020 Aug 13, 2020	SELL	$46.91 - $78.22 $93,820 - $156,440	-2,000 Reduced 9.09%	20,000 $1.56 Million
Q1 2020 May 14, 2020	BUY	$33.8 - $62.9 $743,599 - $1.38 Million	22,000 New	22,000 $977,000

287

88.1M

505K

198K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.76B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.